Circulation, Vol 77, 712-719, Copyright © 1988 by American Heart Association
SA Camacho, J Wikman-Coffelt, ST Wu, TA Watters, EH Botvinick, R Sievers, TL James, G Jasmin and WW Parmley
To determine the effect of isoproterenol on cardiac energetics and function
in an animal preparation of cardiomyopathy, we studied Langendorff perfused
hearts from Syrian cardiomyopathic hamsters. High- energy phosphate
metabolites (phosphocreatine [PCr], ATP, inorganic phosphate [Pi]) and
intracellular pH (pHi) were measured by 31P nuclear magnetic resonance
spectroscopy and correlated with left ventricular developed pressure,
coronary flow, and O2 consumption before and during a 10(-6)M infusion of
isoproterenol. Total intracellular calcium was also determined by atomic
absorption spectroscopy with the use of potassium ethylenediamine
tetra-acetate cobaltate as a marker for extracellular space. In
cardiomyopathic hamsters, isoproterenol infusion increased mean developed
pressure by 300% (p less than .005 compared with control; n = 5), O2
consumption eightfold (p less than .0005), and PCr by 40% (p less than
.05). PCr/Pi ratio, which is analogous to phosphorylation potential,
improved 100% (p = .05). In normal hamsters, isoproterenol infusion
resulted in an 83% increase in developed pressure (p less than .001) and a
25% increase in O2 consumption (NS). However, mean PCr and PCr/Pi decreased
by 30% and 50%, respectively (p less than .05 for both), during
isoproterenol infusion. pHi decreased in normal animals (p less than .01),
but tended to improve in diseased animals (NS) during isoproterenol
infusion. Freeze-clamp measurements of phosphate metabolites correlated
well with the nuclear magnetic resonance data. Intracellular calcium
increased from 0.0102 +/- 0.002 to 0.144 +/- 0.030 mumol/ml heart water in
normal hamsters during isoproterenol infusion. Cardiomyopathic hamsters had
a markedly elevated baseline calcium content of 60.82 +/- 5.85 mumol/ml
heart water due to the presence of dystrophic calcification.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Improvement in myocardial performance without a decrease in high-energy phosphate metabolites after isoproterenol in Syrian cardiomyopathic hamsters
Department of Medicine (Cardiology), University of California, San Francisco 94143.
This article has been cited by other articles:
![]() |
L. T. McGrath, R. Patrick, and B. Silke Breath isoprene in patients with heart failure Eur J Heart Fail, August 1, 2001; 3(4): 423 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueyama, T. Ohkusa, M. Yano, and M. Matsuzaki Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters Cardiovasc Res, October 1, 1998; 40(1): 64 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ueyama, T. Ohkusa, Y. Hisamatsu, Y. Nakamura, T. Yamamoto, M. Yano, and M. Matsuzaki Alterations in cardiac SR Ca2+-release channels during development of heart failure in cardiomyopathic hamsters Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H1 - H7. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nascimben, J. Friedrich, R. Liao, P. Pauletto, A. C. Pessina, and J. S. Ingwall Enalapril Treatment Increases Cardiac Performance and Energy Reserve Via the Creatine Kinase Reaction in Myocardium of Syrian Myopathic Hamsters With Advanced Heart Failure Circulation, March 15, 1995; 91(6): 1824 - 1833. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |